Global Antinuclear Antibody Test Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	207 Pages	TechNavio	May, 2025	INF20056730

Best Price Guarantee
Price	from $2,500
Length	207 Pages
Publisher	TechNavio
Published Date	May, 2025
SKU	INF20056730

Antinuclear Antibody Test Market 2025-2029

The antinuclear antibody test market is forecasted to grow by USD 433.9 mn during 2024-2029, accelerating at a CAGR of 7.3% during the forecast period. The report on the antinuclear antibody test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for ana tests, rising government initiatives, and rising number of reagent rental agreements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's antinuclear antibody test market is segmented as below:

By Application

Autoimmune diseases
Infectious diseases

By Technique

Enzyme-linked immunosorbent assay
Indirect immunofluorescence
Multiplex assay
Others

By End-user

Hospitals
Clinical diagnostic laboratories

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing prevalence of autoimmune diseases as one of the prime reasons driving the antinuclear antibody test market growth during the next few years. Also, rising population and healthcare expenditure and increasing geriatric population will lead to sizable demand in the market.

The report on the antinuclear antibody test market covers the following areas:

Antinuclear Antibody Test Market sizing
Antinuclear Antibody Test Market forecast
Antinuclear Antibody Test Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antinuclear antibody test market vendors that include Abbott Laboratories, Abcam plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, Perkin Elmer Inc., QuidelOrtho Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc.. Also, the antinuclear antibody test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Technique; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Antinuclear Antibody Test Market 2019 - 2023; Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2019 - 2023 ($ million); 5.2 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million); 5.3 Technique segment analysis 2019 - 2023; Historic Market Size - Technique Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI in global antinuclear antibody test market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application: 8.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 8.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 8.3 Autoimmune diseases - Market size and forecast 2024-2029; Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million); Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million); Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%); 8.4 Infectious diseases - Market size and forecast 2024-2029; Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Technique: 9.1 Market segments; Chart on Technique - Market share 2024-2029 (%); Data Table on Technique - Market share 2024-2029 (%); 9.2 Comparison by Technique; Chart on Comparison by Technique; Data Table on Comparison by Technique; 9.3 Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029; Chart on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million); Data Table on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million); Chart on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%); Data Table on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%); 9.4 Indirect immunofluorescence - Market size and forecast 2024-2029; Chart on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million); Data Table on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million); Chart on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%); Data Table on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%); 9.5 Multiplex assay - Market size and forecast 2024-2029; Chart on Multiplex assay - Market size and forecast 2024-2029 ($ million); Data Table on Multiplex assay - Market size and forecast 2024-2029 ($ million); Chart on Multiplex assay - Year-over-year growth 2024-2029 (%); Data Table on Multiplex assay - Year-over-year growth 2024-2029 (%); 9.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.7 Market opportunity by Technique; Market opportunity by Technique ($ million); Data Table on Market opportunity by Technique ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 10.4 Clinical diagnostic laboratories - Market size and forecast 2024-2029; Chart on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Data Table on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Chart on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%); Data Table on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.11 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.12 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.14 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 12.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.16 Mexico - Market size and forecast 2024-2029; Chart on Mexico - Market size and forecast 2024-2029 ($ million); Data Table on Mexico - Market size and forecast 2024-2029 ($ million); Chart on Mexico - Year-over-year growth 2024-2029 (%); Data Table on Mexico - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; SWOT; 15.5 Abcam plc; Abcam plc - Overview; Abcam plc - Product / Service; Abcam plc - Key news; Abcam plc - Key offerings; SWOT; 15.6 Antibodies Inc.; Antibodies Inc. - Overview; Antibodies Inc. - Product / Service; Antibodies Inc. - Key offerings; SWOT; 15.7 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; SWOT; 15.8 BioVision Inc.; BioVision Inc. - Overview; BioVision Inc. - Product / Service; BioVision Inc. - Key offerings; SWOT; 15.9 Grifols SA; Grifols SA - Overview; Grifols SA - Business segments; Grifols SA - Key news; Grifols SA - Key offerings; Grifols SA - Segment focus; SWOT; 15.10 Immuno Concepts Ltd.; Immuno Concepts Ltd. - Overview; Immuno Concepts Ltd. - Product / Service; Immuno Concepts Ltd. - Key offerings; SWOT; 15.11 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; SWOT; 15.12 Orgentec Diagnostika GmbH; Orgentec Diagnostika GmbH - Overview; Orgentec Diagnostika GmbH - Product / Service; Orgentec Diagnostika GmbH - Key offerings; SWOT; 15.13 Perkin Elmer Inc.; Perkin Elmer Inc. - Overview; Perkin Elmer Inc. - Business segments; Perkin Elmer Inc. - Key offerings; Perkin Elmer Inc. - Segment focus; SWOT; 15.14 QuidelOrtho Corp.; QuidelOrtho Corp. - Overview; QuidelOrtho Corp. - Product / Service; QuidelOrtho Corp. - Key news; QuidelOrtho Corp. - Key offerings; SWOT; 15.15 Seramun Diagnostica GmbH; Seramun Diagnostica GmbH - Overview; Seramun Diagnostica GmbH - Product / Service; Seramun Diagnostica GmbH - Key offerings; SWOT; 15.16 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; SWOT; 15.17 Werfenlife SA; Werfenlife SA - Overview; Werfenlife SA - Product / Service; Werfenlife SA - Key offerings; SWOT; 15.18 ZEUS Scientific Inc.; ZEUS Scientific Inc. - Overview; ZEUS Scientific Inc. - Product / Service; ZEUS Scientific Inc. - Key offerings; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Technique; Exhibits7: Executive Summary - Chart on Market Segmentation by End-user; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Technique Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Application - Market share 2024-2029 (%); Exhibits39: Data Table on Application - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Application; Exhibits41: Data Table on Comparison by Application; Exhibits42: Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits50: Market opportunity by Application ($ million); Exhibits51: Data Table on Market opportunity by Application ($ million); Exhibits52: Chart on Technique - Market share 2024-2029 (%); Exhibits53: Data Table on Technique - Market share 2024-2029 (%); Exhibits54: Chart on Comparison by Technique; Exhibits55: Data Table on Comparison by Technique; Exhibits56: Chart on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%); Exhibits60: Chart on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%); Exhibits64: Chart on Multiplex assay - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Multiplex assay - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Multiplex assay - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Multiplex assay - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits72: Market opportunity by Technique ($ million); Exhibits73: Data Table on Market opportunity by Technique ($ million); Exhibits74: Chart on End-user - Market share 2024-2029 (%); Exhibits75: Data Table on End-user - Market share 2024-2029 (%); Exhibits76: Chart on Comparison by End-user; Exhibits77: Data Table on Comparison by End-user; Exhibits78: Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%); Exhibits86: Market opportunity by End-user ($ million); Exhibits87: Data Table on Market opportunity by End-user ($ million); Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits91: Chart on Geographic comparison; Exhibits92: Data Table on Geographic comparison; Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on Mexico - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on Mexico - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on Mexico - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on Mexico - Year-over-year growth 2024-2029 (%); Exhibits149: Market opportunity By Geographical Landscape ($ million)